Search for a trial

A phase IIIb, open, multi-centre gynaecological extension study for the follow-up of a subset of HPV-015 study subjects

To provide clinical management and, if required, treatment to subjects who at their concluding HPV-015 study visit displayed normal cervical cytology but tested positive for oncogenic HPV infection or who were pregnant at their concluding visit of…

MeD-seq, a novel assay for genome-wide DNA methylation profiling in developing predictive biomarkers of gynaecological cancer and endometriosis

1. To study the possibility to detect gynaecological malignancies and endometriosis in Pap smears and blood of women with gynaecological cancer or endometriosis, using MeD-seq and biomarker assays, in order to develop new reliable screening methods…

Reliability, validation and acceptance of a novel self-lavaging collection device, MySampleTM, in combination with the HPV-Risk Assay and QIAsure Methylation test to screen for cervical cancer.

This study is to answer two questions. First the reliability and validity of the novel lavage method to screen on cervical cancer in combination with the clinically validated hrHPV and hypermethylation triage tests. Second the functionality and…